{
    "clinical_study": {
        "@rank": "167977", 
        "arm_group": {
            "arm_group_label": "Sleep apnea", 
            "description": "Those suspected of sleep apnea and scheduled for polysomnography and treated with CPAP therapy."
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to check blood and urine levels to further define markers/tests\n      in the blood and urine that would be useful in following patients with obstructive sleep\n      apnea and then to see if by wearing CPAP every night, these markers can be reduced. This\n      research is being done because currently there are no effective blood or urine markers to\n      determine how well CPAP is working."
        }, 
        "brief_title": "Oxidative Stress in Obstructive Sleep Apnea: Correlation of Biomarkers and Nasal CPAP Compliance", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Sleep Apnea, Obstructive", 
        "condition_browse": {
            "mesh_term": [
                "Apnea", 
                "Sleep Apnea Syndromes", 
                "Sleep Apnea, Obstructive"
            ]
        }, 
        "detailed_description": {
            "textblock": "The goal of this study is to further define biomarkers that would be useful in following\n      patients with obstructive sleep apnea and examining their response to compliance to therapy\n      with CPAP.  To date no correlation between biomarkers of oxidative stress and compliance to\n      CPAP has been measured.  CPAP is the most effective treatment for obstructive sleep apnea\n      and has been show to reduce blood pressure and decrease oxidative stress."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Men and Women over 18 years suspected of having sleep apnea\n\n        Exclusion Criteria:\n\n          -  Those under 18 years or not suspected of having sleep apnea"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Those over 18 years suspected of having sleep apnea."
            }
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 3, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01661699", 
            "org_study_id": "2011-416"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Obstructive Sleep Apnea", 
        "lastchanged_date": "July 30, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Washington", 
                    "country": "United States", 
                    "state": "District of Columbia", 
                    "zip": "20007"
                }, 
                "name": "Georgetown University Hospital"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Oxidative Stress in Obstructive Sleep Apnea: Correlation of Biomarkers and Nasal CPAP Compliance", 
        "overall_official": {
            "affiliation": "Georgetown University", 
            "last_name": "Cristina Reichner, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The primary objective of this pilot study will determine the biomarkers for polysomnography characteristics with CPAP treatment from baseline to 6 months in patients with obstructive sleep apnea. The results will guide biomarker selection for full scale studies.", 
            "measure": "Determining biomarkers for polysomnography characteristics before and after CPAP treatment", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01661699"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Georgetown University", 
            "investigator_full_name": "Christina Reichner, M.D.", 
            "investigator_title": "M.D., Associate Professor Medicine", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Georgetown University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Georgetown University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2011", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "July 2013"
    }
}